Disease Characteristics, Patterns of Care, and Survival in Very Elderly Patients with Diffuse Large B-Cell Lymphoma

BACKGROUND: Although rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is considered standard therapy for diffuse large B-cell lymphoma (DLBCL), patterns of use and the impact of R-CHOP on survival in patients >80 years are less clear. METHODS: We used the Surveillanc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Williams, Jessica N., Rai, Ashish, Lipscomb, Joseph, Koff, Jean L., Nastoupil, Loretta J., Flowers, Christopher R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4441579/
https://ncbi.nlm.nih.gov/pubmed/25675909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29290
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky